Blinatumomab for B-cell ALL Relapse, IVIG for MIS-C, Review of Irritable Bowel Syndrome, and more
Editor's Summary by Mary McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the March 2, 2021 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - March 2, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts

Counting research rodents, a possible cause for irritable bowel syndrome, and spitting cobras
Online News Editor David Grimm joins host Sarah Crespi to discuss a controversial new paper that estimates how many rodents are used in research in the United States each year. Though there is no official number, the paper suggests there might be more than 100 million rats and mice housed in research facilities in the country—doubling or even tripling some earlier estimates. Next, Staff Writer Jennifer Couzin-Frankel talks with Sarah about a new theory behind the cause of irritable bowel syndrome—that it might be a localized allergic reaction in the gut. Sarah also chats with Taline Kazandjian, a postdoctoral...
Source: Science Magazine Podcast - January 21, 2021 Category: Science Authors: Science Magazine Source Type: podcasts

Counting research rodents, a possible cause for irritable bowel syndrome, and spitting cobras
Online News Editor David Grimm joins host Sarah Crespi to discuss a controversial new paper that estimates how many rodents are used in research in the United States each year. Though there is no official number, the paper suggests there might be more than 100 million rats and mice housed in research facilities in the country—doubling or even tripling some earlier estimates. Next, Staff Writer Jennifer Couzin-Frankel talks with Sarah about a new theory behind the cause of irritable bowel syndrome—that it might be a localized allergic reaction in the gut. Sarah also chats with Taline Kazandjian, a postdoctoral researc...
Source: Science Magazine Podcast - January 21, 2021 Category: Science Authors: Science Magazine Source Type: podcasts

Counting research rodents, a possible cause for irritable bowel syndrome, and spitting cobras
Online News Editor David Grimm joins host Sarah Crespi to discuss a controversial new paper that estimates how many rodents are used in research in the United States each year. Though there is no official number, the paper suggests there might be more than 100 million rats and mice housed in research facilities in the country —doubling or even tripling some earlier estimates. Next, Staff Writer Jennifer Couzin-Frankel talks with Sarah about a new theory behind the cause of irritable bowel syndrome—that it might be a localized allergic reaction in the gut. Sarah also chats with Taline Kazandjian, a postdoctoral resear c...
Source: Science Magazine Podcast - January 21, 2021 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts

Counting research rodents, a possible cause for irritable bowel syndrome, and spitting cobras
Online News Editor David Grimm joins host Sarah Crespi to discuss a controversial new paper that estimates how many rodents are used in research in the United States each year. Though there is no official number, the paper suggests there might be more than 100 million rats and mice housed in research facilities in the country —doubling or even tripling some earlier estimates. Next, Staff Writer Jennifer Couzin-Frankel talks with Sarah about a new theory behind the cause of irritable bowel syndrome—that it might be a localized allergic reaction in the gut. Sarah also chats with Taline Kazandjian, a postdoctoral rese a...
Source: Science Magazine Podcast - January 19, 2021 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts

FDA Drug Safety Podcast: FDA warns about increased risk of serious pancreatitis with irritable bowel drug Viberzi (eluxadoline) in patients without a gallbladder
FDA Drug Safety Podcast: FDA warns that Viberzi (eluxadoline), a medicine used to treat irritable bowel syndrome with diarrhea (IBS-D), should not be used in patients who do not have a gallbladder. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - February 9, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts

FDA Drug Safety Podcast: FDA warns about increased risk of serious pancreatitis with irritable bowel drug Viberzi (eluxadoline) in patients without a gallbladder
On March 15, 2017, FDA announced it is warning that Viberzi (active ingredient eluxadoline), a medicine used to treat irritable bowel syndrome with diarrhea (IBS-D), should not be used in patients who do not have a gallbladder. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - March 22, 2017 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts

Optimizing the Management of Irritable Bowel Syndrome With Constipation (IBS-C) and Chronic Idiopathic Constipation (CIC): Evidence-Based Strategies to Reduce the Burden of Disease and Improve Patient Care and Satisfaction
(Source: PeerView CME/CE Audio Podcast - Primary Care)
Source: PeerView CME/CE Audio Podcast - Primary Care - November 18, 2015 Category: Primary Care Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

An intervention to improve housing stability for homeless adults with mental illness, lorazepam before general anesthesia, the natural history of benign thyroid nodules, review of irritable bowel syndrome, and more.
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the March 03, 2015 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - March 3, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

Constipation: What Works, What Doesn't
Dr David Johnson reviews the supportive evidence and recommendations for all of the available treatments for chronic constipation and irritable bowel syndrome. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - January 14, 2015 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts

Antidepressants and Psychological Therapies in IBS
Is it time to consider psychological approaches to irritable bowel syndrome an important component of care? (Source: Medscape Gastroenterology Podcast)
Source: Medscape Gastroenterology Podcast - August 26, 2014 Category: Gastroenterology Authors: Medscape Source Type: podcasts

Antidepressants and Psychological Therapies in IBS
Is it time to consider psychological approaches to irritable bowel syndrome an important component of care? (Source: Medscape Psychiatry Podcast)
Source: Medscape Psychiatry Podcast - August 26, 2014 Category: Psychiatry Authors: Medscape Source Type: podcasts

Irritable Bowel Disease – Crohn’s Disease and Ulcerative Colitis
Dr. Kerry Hammond, assistant professor of surgery at the Digestive Disease Center at MUSC, discusses Irritable Bowel Disease, the most common forms of which are Crohn’s Disease and Ulcerative Colitis. She explains what conditions may warrant a surgical procedure (either planned or emergent) for a patient with Irritable Bowel Disease, and what studies may be conducted prior to surgery. Dr. Hammond concludes this podcast by outlining what preventative measures a patient with Ulcerative Colitis should take due to the increased risk of cancer associated with the disease. (Source: MUSC Digestive Health Podcast)
Source: MUSC Digestive Health Podcast - April 5, 2014 Category: Gastroenterology Authors: Medical University of South Carolina Source Type: podcasts

The Pathophysiology of Irritable Bowel Syndrome
Dr Camilleri explicates the peripheral mechanisms central to our improved understanding of irritable bowel syndrome. (Source: MedscapeCME Gastroenterology Podcast)
Source: MedscapeCME Gastroenterology Podcast - February 21, 2013 Category: Gastroenterology Authors: MedscapeCME Source Type: podcasts

Rome Criteria of Irritable Bowel Syndrome: Pro and Con Perspectives
Do symptom-based, Rome criteria for IBS lead to better diagnosis and treatment outcomes? Dr. Kuemmerle speaks to two authors of articles in the February 2010 CGH that offer pro and con perspectives. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 29, 2010 Category: Gastroenterology Authors: AGA Source Type: podcasts